搜索临床试验以:Flumatinib, CML-CP with Ph
总计319564个结果
-
Wuhan Union Hospital, China招聘中
-
Novartis Pharmaceuticals主动,不招人
-
Novartis Pharmaceuticals主动,不招人
-
Ascentage Pharma Group Inc.HealthQuest Pharma Inc.主动,不招人
-
Novartis Pharmaceuticals完全的
-
Novartis Pharmaceuticals终止慢性粒细胞白血病 | 费城染色体阳性 (Ph+) | 低伊马替尼谷水平的慢性粒细胞白血病慢性期 (CML-CP) 患者美国
-
Il-Yang Pharm. Co., Ltd.完全的血液病 | 白血病 | 白血病,骨髓 | 白血病,骨髓性,慢性,BCR-ABL 阳性 | 费城染色体印度, 大韩民国, 泰国
-
Novartis Pharmaceuticals完全的
-
Novartis Pharmaceuticals完全的
-
Yunfeng ChengShanghai Zhongshan Hospital; Shanghai Jinshan Hospital; Macau University of Science and Technology... 和其他合作者招聘中
-
Yunfeng ChengShanghai Zhongshan Hospital; Shanghai Jinshan Hospital; Macau University of Science and Technology... 和其他合作者招聘中
-
Vanderbilt University Medical Center尚未招聘心血管疾病 | 射血分数降低的心力衰竭 | 射血分数保留的心力衰竭
-
Yunfeng ChengShanghai Zhongshan Hospital; Shanghai Jinshan Hospital; Macau University of Science and Technology... 和其他合作者招聘中
-
Shanghai Pulmonary Hospital, Shanghai, China招聘中
-
IDeA States Pediatric Clinical Trials NetworkNational Institutes of Health (NIH); University of Kansas尚未招聘
-
Cardiovascular and Interventional Radiological...Boston Scientific Corporation尚未招聘
-
Medisch Spectrum TwenteHaukeland University Hospital尚未招聘
-
Teva Branded Pharmaceutical Products R&D, Inc.尚未招聘
-
Austin Neuromuscular CenterRegeneron Pharmaceuticals尚未招聘
-
University of Texas Southwestern Medical CenterAlbert Einstein College of Medicine; National Institute of Neurological Disorders and Stroke... 和其他合作者招聘中
-
University of Texas Southwestern Medical CenterNational Cancer Institute (NCI)尚未招聘
-
Institut de cancérologie Strasbourg EuropeLEAF4Life, Inc.尚未招聘
-
Sentido's CAIP & CICI Organización Terapéutica招聘中
-
Yunnan Cancer Hospital招聘中
-
Memorial Sloan Kettering Cancer CenterGilead Sciences招聘中
-
Institut de Recherches Internationales Servier尚未招聘IDH1突变型神经胶质瘤 | IDH2突变型神经胶质瘤
-
ARIA Research Pty LtdUniversity of Sydney尚未招聘